Clinical Trial Update: A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™ [Phase 4]

View source ↗

Summary

This clinical trial update reports results from a second open-label extension of a Phase IV study evaluating adjunctive Lovaza (omega-3-acid ethyl esters) thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Antara (fenofibrate)
• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertriglyceridemia | Phase 4 | Status: COMPLETED | Results posted: 2009-07-28